Cancer, Prostate Clinical Trials

• Diet and PSA Levels in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Positioning and Tracking the Prostate During External Beam Radiation
  ClinicalTrials.gov Identifier: NCT00123838 - Active, not recruiting
  Prostate Cancer; Cancer of Prostate; Neoplasms, Prostate
  
• Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005960 - Active, not recruiting
  stage II prostate cancer; Pain; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003084 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00020995 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004928 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• A Study of Docetaxel Plus Carboplatin in Patients with Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00134706 - Active, not recruiting
  Prostate Cancer; Cancer of the Prostate; Cancer of Prostate
  
• Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
  
• Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002889 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• PET Scan in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002981 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005947 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00084526 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002723 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003903 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; Osteoporosis
  
• Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00077402 - Active, not recruiting
  recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006114 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00030277 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003400 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• 17-AAG in Treating Patients with Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00118092 - Active, not recruiting
  recurrent prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer
  
• Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00019695 - Active, not recruiting
  Stage IV Prostate Cancer; Bone Metastases; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
  
• Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082680 - Active, not recruiting
  recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate
  ClinicalTrials.gov Identifier: NCT00030290 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer
  
• Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
  ClinicalTrials.gov Identifier: NCT00003858 - Active, not recruiting
  stage III prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer; stage I prostate cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003633 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Lycopene in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00068731 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003871 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• GVAX® Prostate Cancer Vaccine vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089856 - Active, not recruiting
  Prostate Cancer
  
• Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00054509 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
  
• Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00080899 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003533 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082732 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003516 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00085228 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002760 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
  
• NCI HIGH PRIORITY CLINICAL TRIAL --- Prostatectomy Compared With Watchful Waiting in Treating Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002606 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
  
• CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00004026 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)
  ClinicalTrials.gov Identifier: NCT00090363 - Active, not recruiting
  Prostate Cancer
  
• Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002602 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00110162 - Recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
  
• Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002511 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003534 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00052845 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005992 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
  ClinicalTrials.gov Identifier: NCT00078923 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00028574 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer; Hot Flashes
  
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002597 - Active, not recruiting
  stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00043069 - Active, not recruiting
  Osteoporosis; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
  ClinicalTrials.gov Identifier: NCT00071968 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
  
• Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00039104 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
  ClinicalTrials.gov Identifier: NCT00045123 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
  ClinicalTrials.gov Identifier: NCT00005073 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer; Quality of Life
  
• Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00046826 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00024414 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003183 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00017576 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Atrasentan in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00046943 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006023 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016107 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002703 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
  
• Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00122265 - Active, not recruiting
  Prostate Cancer
  
• Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082693 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00003622 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
  ClinicalTrials.gov Identifier: NCT00031746 - Active, not recruiting
  Prostate Cancer
  
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Clinical Trial for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
  Prostate Cancer
  
• Cilengitide in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00103337 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer
  
• Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00017563 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00022412 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
  
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
  ClinicalTrials.gov Identifier: NCT00056407 - Active, not recruiting
  Prostate Cancer
  
• Evaluate Risk Factors which Predict the Transformation of Early Stage to Clinically Aggressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00011349 - Active, not recruiting
  Prostate Cancer
  
• Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00014352 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; Thromboembolism; recurrent prostate cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00003391 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Brachytherapy in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005939 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
  
• Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060086 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Assessment of Primary Androgen Deprivation Therapy for Non-Metastatic Prostate Cancer Among Elderly
  ClinicalTrials.gov Identifier: NCT00161252 - Recruiting
  Prostate Cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00054574 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Cilengitide in Treating Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00121238 - Recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
  ClinicalTrials.gov Identifier: NCT00030901 - Active, not recruiting
  Prostate Cancer
  
• Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00031889 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• 3-AP in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00054015 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer
  
• A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
  ClinicalTrials.gov Identifier: NCT00087659 - Active, not recruiting
  Prostate Cancer
  
• MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00027781 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00027794 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Selenium and Vitamin E in Preventing Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006392 - Active, not recruiting
  Prostate Cancer